| abstract |
The present invention relates to the compound (2R) -2- (6- {5-chloro-2-[(oxane-4-yl) amino] pyrimidin-4-yl} -1-oxo-2,3-dihydro- 1H-isoindole-2-yl) -N-[ (1S) -1- (3-fluoro-5-methoxyphenyl) -2-hydroxyethyl] propanamide, especially the novel physics of the compound Type, a method of preparing the compound and a synthetic intermediate for use in a process, including new formulations of the compound, and therapeutic uses of the compound. |